We are interested in understanding how breast cancers escape targeted therapeutic inhibition, and the molecular mechanisms promoting epithelial mesenchymal transition, cellular invasion, and drug resistance. Using a multidisciplinary approach that integrates molecular, cellular, genetic, pathological, immunological, and pharmacological strategies, our current research focuses on growth factor receptor and kinase crosstalk, feedback and compensatory signaling, and transcription factor modulation in the context of pharmacological resistance and disease progression of breast cancers.
Click here to learn more about our research.
Rita Nahta, PhD
Department of Pharmacology
Department of Hematology & Medical Oncology
Emory University School of Medicine
Winship Cancer Institute C5005A